Transforming Growth Factor β Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab

door Wang, Shizhen Emily, Xiang, Bin, Guix, Marta, Olivares, Maria Graciela, Parker, Joel, Chung, Christine H., Pandiella, Atanasio, Arteaga, Carlos L.
Gepubliceerd in 2008

Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins

door Guix, Marta, Faber, Anthony C., Wang, Shizhen Emily, Olivares, Maria Graciela, Song, Youngchul, Qu, Sherman, Rinehart, Cammie, Seidel, Brenda, Yee, Douglas, Arteaga, Carlos L., Engelman, Jeffrey A.
Gepubliceerd in 2008

Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase

door Garrett, Joan T., Olivares, María Graciela, Rinehart, Cammie, Granja-Ingram, Nara D., Sánchez, Violeta, Chakrabarty, Anindita, Dave, Bhuvanesh, Cook, Rebecca S., Pao, William, McKinely, Eliot, Manning, H. C., Chang, Jenny, Arteaga, Carlos L.
Gepubliceerd in 2011

Imaging biomarkers to predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer

door Shah, Chirayu, Miller, Todd W., Wyatt, Shelby K., McKinley, Eliot T., Olivares, Maria Graciela, Sanchez, Violeta, Nolting, Donald D., Buck, Jason R., Zhao, Ping, Ansari, M. Sib, Baldwin, Ronald M., Gore, John C., Schiff, Rachel, Arteaga, Carlos L., Manning, H. Charles
Gepubliceerd in 2009